CONMED Corp — Director's Dealing 2020

Jun 8, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2020-06-05

Reporting Person: Ruiz-Caban Wilfredo (EVP QA, RA and Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-05	Common Stock	M	23360	$39.87	Acquired	25592	Direct
2020-06-05	Common Stock	F	16555	$81.29	Disposed	9037	Direct
2020-06-05	Common Stock	M	18000	$41.93	Acquired	27037	Direct
2020-06-05	Common Stock	F	13167	$81.03	Disposed	13870	Direct
2020-06-05	Common Stock	S	9919	$82.02	Disposed	3951	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-05	Options To Purchase Common Stock	$39.87	M	23360	Disposed	2026-03-01	Common Stock (23360)	Direct
2020-06-05	Options To Purchase Common Stock	$41.93	M	18000	Disposed	2027-03-01	Common Stock (18000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.56 to $82.74. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period